Page 53 - Pengawalan Badan POM dalam Penyediaan Vaksin COVID-19

Judul : Indonesian Team in China for Covid-19 Vaccine Safety Audit

Nama Media : jakartaglobe.id

Tanggal : 17 Oktober 2020

Halaman/URL : https://jakartaglobe.id/news/indonesian-team-in-china-for-covid19-
vaccine-safety-audit

Tipe Media : Online

A team from the Food and Drug Control
Agency, or BPOM, left for China on
Thursday to inspect production process at
three Covid-19 vaccine factories, from
which Indonesia has secured a supply
commitment.

The team will visit the production sites of
Sinovac, Sinofarm and Cansino vaccines
to make sure that they are high in quality
for the intended use and manufactured in compliance with good manufacturing
practice, according to BPOM’s drug registration director Lucia Rizka Andalusia.

“The team also comprises officials from the Health Ministry, the Indonesian Ulema
Council (MUI) and state-run pharmaceutical firm Bio Farma,” Lucia said in a video
conference.

The Indonesian government has secured a supply of those vaccines, including 143
million doses of Sinovac vaccine, 15 million doses of Sinofarm and 100,000 doses of
Cansiono for shipments starting from late December.

The vaccine will first go to 3.4 million people in the priority group, which includes
medical workers and law enforcement officers.

The government has targeted to vaccinate 135 million people in 2021, each will
receive two doses of the vaccine.
Indonesia is recruiting 1,620 volunteers for the phase 3 of Sinovac vaccine clinical
trial in the West Java capital of Bandung.

Earlier on Sunday, Coordinating Minister for the Economy Airlangga Hartarto said
the government has struck a deal to procure 100 million doses of vaccines from
British pharmaceutical company AstraZeneca.

"The government will pay a 50 percent down payment by the end of this month. The
cost for that is about $250 million," Airlangga said.
The country has recorded 349,160 confirmed cases of coronavirus as of Thursday,
including 12,268 deaths. More than 63,000 Covid-19 patients are still battling the
disease across 34 provinces.